Oracle (NYSE:ORCL) has launched a Life Sciences AI Data Platform using generative AI to support drug development and clinical research. The company also reported new enterprise wins, including IHG ...

Oracle is considering workforce cuts and selling Cerner to alleviate financial pressure, warns investment bank TD Cowen.

Oracle (NYSE:ORCL) looked like it was destined to be the next $1 trillion company last year before things made an abrupt turn ...

Oracle remains a high-risk, high-potential-reward artificial intelligence stock.

The $500 billion price tag attached to Oracle and OpenAI’s next generation of AI data centers is forcing investors to ...

Morgan Stanley cuts target 30% to $213 on AI funding fears while Guggenheim holds $400 target. Wall Street divided on cloud ...

Oracle cofounder Larry Ellison believes today’s leading AI models are fundamentally limited because they are trained on the ...

Oracle (ORCL) was in focus on Thursday as Wall Street firms defended the IT giant after it reported mixed results, and said the growth from artificial intelligence will be surprising in the years to ...

Look at Oracle if you want to assess the sustainability of the AI investment boom: Its credit default swaps are emerging as a way to 'hedge the entire debt cycle within AI' For a few brief weeks in ...

Oracle has become the market's favorite stress test for artificial intelligence exuberance, a company whose every earnings line and debt decision now doubles as a referendum on whether the AI trade ...

A majority of early users say Oracle Health’s new Clinical AI Agent is reducing documentation time and easing clinician burnout, according to a Nov. 12 KLAS Research report. KLAS interviewed 17 ...

Oracle has lost more than $463 billion in value since hitting a record high of $933 billion in September 2025. That drop, ...